Chemomab Therapeutics (CMMB) Earnings Date & Reports

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CMMB is expected to report earnings to rise 900.00% to -10 cents per share on August 08

Chemomab Therapeutics CMMB Stock Earnings Reports

Q2'25

Est.

$-0.10

Q1'25

Est.

$-0.01

Q4'24

Beat

by $0.05

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.09

The last earnings report on May 15 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 98.97K shares outstanding, the current market capitalization sits at 26.21M.

View a ticker or compare two or three

Compare

CMMB